title: Extramammary Paget's disease of the vulva.
abstract: Fourteen patients with extramammary Paget's disease of the vulva treated at Yale-New Haven Medical Center from 1982 through 1993 were reviewed to evaluate the accuracy of methods used to delineate surgical margins and to determine if radical operations or surgical margin status was associated with likelihood of recurrence. These 14 patients underwent at total of 25 operations for extramammary Paget's disease. In 8 operations, a total of 44 separate frozen-section biopsies were performed to determine extent of disease with a mean of 5.5 biopsies per patient. Visual judgment alone was used to determine margin status in 17 operations. The ability to delineate free surgical margins on permanent sections was not different, whether judged visually or by frozen-section analysis. Frozen-section analysis was misleading in 3/8 (37.5%) cases, while visual judgment was in error in 6/17 (35%) cases. Moreover, permanent margin status was not found to be predictive of disease recurrence. Two of 5 (40%) patients with positive margins recurred after initial surgery compared with 3 of 9 (33%) patients with negative margins. Of the 14 primary operations, there were 8 wide local excisions, 3 simple vulvectomies, and 3 modified radical vulvectomies. The radicality of the operation as initial treatment did not statistically correlate with disease recurrence.
authors.affiliation: Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
authors.forename: D A
authors.initials: DA
authors.lastname: Fishman
authors.forename: S K
authors.initials: SK
authors.lastname: Chambers
authors.forename: P E
authors.initials: PE
authors.lastname: Schwartz
authors.forename: E I
authors.initials: EI
authors.lastname: Kohorn
authors.forename: J T
authors.initials: JT
authors.lastname: Chambers
mesh_terms: D005260:Female; D006801:Humans; D010385:Pelvic Exenteration; D012189:Retrospective Studies; D013518:Surgery, Plastic; D013524:Surgical Flaps / Q000009:adverse effects*; D002583:Uterine Cervical Neoplasms / Q000601:surgery; D014621:Vagina / Q000601:surgery*; D014625:Vaginal Neoplasms / Q000601:surgery; D014844:Vulva / Q000601:surgery*; D014846:Vulvar Neoplasms / Q000601:surgery